SLC25A17 and carcinoma: In the TCGA-HNSC cohort of 504 tumor tissues and 44 normal para-carcinoma tissues, the expression of SLC25A17 in tumor tissues was significantly higher than that in normal para-carcinoma tissues (Fig. 1B, C), and IHC slides from THPA also supported the result (Fig. 1D).